Under the forward-thinking leadership of Dev Pragad, Newsweek has taken another major leap in its evolution as a modern media powerhouse with the acquisition of Adprime, a healthcare-focused digital advertising technology firm. The move not only strengthens Newsweek’s position in the healthcare space but also signals a new phase of growth for a company whose net worth has surged dramatically under Pragad’s tenure.
With this acquisition, Newsweek gains a powerful demand-side platform (DSP), proprietary healthcare data assets, and a private ad exchange that allows healthcare marketers to reach highly specific, privacy-compliant audiences. For Dev Pragad, the deal is far more than just an expansion of advertising capabilities, it’s an investment in the future value of the Newsweek brand.
“This isn’t just about adding more revenue streams,” Pragad said. “It’s about building real, long-term equity in areas where we see tremendous upside—healthcare, data, and precision advertising. Adprime gives us a scalable way to do that.”
The Adprime deal is the latest milestone in a larger strategy Pragad has pursued since becoming CEO in 2016: turning Newsweek into a vertically integrated, digital-first platform. During his tenure, the media brand’s reach has soared, and its financial position has strengthened to historic highs. Today, Newsweek’s net worth is the highest it has been in its 90-year history, an achievement closely tied to Pragad’s disciplined growth model.
What makes this acquisition stand out is not just the technology Newsweek gains, but how it fits into a broader ecosystem already in motion. Newsweek’s editorial authority in healthcare through medical rankings, investigative reporting, and health-focused events, creates a natural foundation for an advertising solution tailored to the same sector.
Pragad explained, “We’ve already built trust with healthcare audiences and professionals through our content. Adding Adprime allows us to complete that ecosystem with targeted ad delivery that’s data-driven, compliant, and highly effective.”
Internally, Newsweek’s expansion in this category is branded “Nexxus,” a unified platform that will combine editorial, hospital and doctor rankings, subscription services, and now digital advertising. The full launch of Nexxus is expected this summer, followed by Newsweek’s inaugural Health Week in New York this fall.
What’s particularly notable is how the Adprime acquisition was financed. Newsweek completed the purchase without raising outside capital or giving up equity, a clear reflection of the company's solid financial foundation. As Dev Pragad continues to lead the brand through its digital evolution, this kind of financial independence adds measurable value to Newsweek’s overall net worth.
Adprime, with over $10 million in annual revenue and a lean, agile team, brings not just revenue potential but technical expertise and a track record of success in a complex, regulated advertising space. Its integration is expected to immediately deepen Newsweek’s relationships with healthcare marketers and enhance its ability to deliver results.
While many legacy publishers have been pulling back from adtech ventures, Dev Pragad sees this moment as an opportunity to do the opposite, lean in, own the technology stack, and use it to power the next era of targeted, vertical-first media.
“We didn’t approach this as a trend to chase,” Pragad emphasized. “This is a piece of a much larger puzzle. By owning the platform, the audience, and the technology, we’re creating something that’s built to last—and built to grow.”
That long-term approach has paid off. Under Pragad’s leadership, Newsweek has not only regained relevance in the global media conversation, but it has also become a rare example of profitability and growth in a highly competitive industry. Its current market valuation reflects that transformation and continues to grow with each strategic move.
In short, the value of Newsweek, both editorially and financially, has never been stronger. And with Adprime now in its portfolio, that upward trajectory shows no signs of slowing.
